Type 1 Diabetes Mellitus Associated with Nivolumab after Second SARS-CoV-2 Vaccination, Japan

Sato, Toshihiro; Kodama, Shinjiro; Kaneko, Keizo; Imai, Junta; Katagiri, Hideki

doi:10.3201/eid2807.220127

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Type 1 Diabetes Mellitus Associated with Nivolumab after Second SARS-CoV-2 Vaccination, Japan

7-2022
By Sato, Toshihiro ; Kodama, Shinjiro ; Kaneko, Keizo ; ...
http://dx.doi.org/10.3201/eid2807.220127
Source: Emerg Infect Dis. 2022; 28(7):1518-1520

[PDF-328.08 KB]

English

Details Supporting Files You May Also Like

Details:

Alternative Title:

Emerg Infect Dis
Personal Author:

Sato, Toshihiro ; Kodama, Shinjiro ; Kaneko, Keizo ; Imai, Junta ; Katagiri, Hideki

Sato, Toshihiro ; Kodama, Shinjiro ; Kaneko, Keizo ; Imai, Junta ; Katagiri, Hideki Less -
Description:

Recently, along with increasing use of immune checkpoint inhibitors such as nivolumab, the incidence of immune-related adverse events, including type 1 diabetes mellitus, has become a serious problem. We report a patient who had immune checkpoint inhibitor‒associated type 1 diabetes mellitus that developed after a second mRNA-based SARS-CoV-2 vaccination.
Subjects:

[+]

Covid-19 Covid-19 Vaccines Diabetes Mellitus, Type 1 Humans Immune Checkpoint Inhibitors Nivolumab Sars-Cov-2 Vaccination
Source:

Emerg Infect Dis. 2022; 28(7):1518-1520
Pubmed ID:

35468049
Pubmed Central ID:

PMC9239866
Document Type:

Letter
Place as Subject:

Japan
Collection(s):

Emerging Infectious Diseases
Main Document Checksum:

[+]

urn:sha256:be4e0af57a1a54017c67eee9b26d7439934cd0d270a3b750d4f80fb43832a58d
Download URL:

https://stacks.cdc.gov/view/cdc/118929/cdc_118929_DS1.pdf
File Type:

	22-0127-F.gif	gif
	22-0127-F.jpg	jpeg
	22-0127.nxml	xml

More +